OSSR.CO
Ossur hf
Price:
35.9
DKK
Volume:
8,830
Iceland | Health Care Equipment & Supplies
Discounted Cash Flow
Trading Multiples
Peter Lynch Fair Value
Earnings Power Value
Dividend Discount Model
WACC
OSSR.CO EV/EBITDA
-16.8 %
Upside
As of 2025-05-17, the EV/EBITDA ratio of Ossur hf (OSSR.CO) is 15.5. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. OSSR.CO's latest enterprise value is 15,327 mil DKK. OSSR.CO's TTM EBITDA according to its financial statements is 149 mil USD. Dividing these 2 quantities gives us the above OSSR.CO EV/EBITDA ratio.
| Range | Selected | |
| Trailing EV/EBITDA multiples | 9.7x - 15.9x | 13x |
| Forward EV/EBITDA multiples | 14.0x - 16.1x | 14.7x |
| Fair Price | 22.37 - 36.83 | 29.87 |
| Upside | -37.7% - 2.6% | -16.8% |
35.90 DKK
Stock Price
29.87 DKK
Fair Price
| (USD in millions except Fair Price) | |||
| Trailing | Forward | ||
| Market Cap (DKK mil) | EV/EBITDA | EV/EBITDA | |
| Ossur hf | 15,327 | 15.5x | 17.8x |
| Carl Zeiss Meditec AG | 41,403 | 19.2x | 17.5x |
| Biomerieux SA | 106,048 | 5.1x | 15.2x |
| Demant A/S | 56,911 | 16.5x | 14.2x |
| Draegerwerk AG & Co KGaA | 7,278 | 2.9x | 3.7x |
| GN Store Nord A/S | 13,974 | 8.4x | 7.6x |
| Prim SA | 1,379 | 4.1x | 5.9x |
| Smith & Nephew PLC | 83,777 | 10.5x | 13.8x |
| Sonova Holding AG | 134,474 | 19.7x | 22.1x |
| Straumann Holding AG | 143,486 | 22.7x | 22.5x |
| Industry median | 13x | 14.7x | |
| (*) EBITDA | 149 | 130 | |
| Enterprise value | 1,938 | 1,907 | |
| (-) Net debt | |||
| Equity value | 1,938 | 1,907 | |
| (/) Outstanding shares | 427 | 427 | |
| Fair price (USD) | 5 | 4 | |
| Fair price (DKK) | 30 | 30 | |